NASDAQ:SLS

Understanding the Risks of Investing in SELLAS Life Sciences Group Inc (SLS)

Daniel Torres

SELLAS Life Sciences Group Inc’s recent filing unveils that its Director VAN NOSTRAND ROBERT L acquired Company’s shares for reported ...

SELLAS Life Sciences Group Inc (SLS) receives an Overweight rating from Cantor Fitzgerald

Anna Perez

SELLAS Life Sciences Group Inc’s filing revealed that its Director VAN NOSTRAND ROBERT L acquired Company’s shares for reported $14800.0 ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.